Neuro-Pain Provides a Dynamic and Interactive Register for the Invasvive Neuromodulatory Therapies for Different Chronic Pain Syndromes. Patients Living in Belgium and Suffering From Persistent Spinal Pain Syndromes Type 2 as Well as Suffering From Complex Regional Pain Syndromes Are Included.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Antwerp

About this trial

Patients suffereing from chronic pain due to persistent spinal pain syndromes or complex regional pain syndromes and living in Belgium will be included in this register once they are being considered for a treatment with invasive neuromodulation (either spinal cord stimulation either dorsal root ganglion stimulation). The screening process, the multidisciplinary evaluation, the trial therapy and the long-terl follow-up will be monitored through this register.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

chronic pain syndromes

Disqualifiers

acute pain syndromes

Trial population

Adult patients suffering from chronic pain syndromes, either persistent spinal pain syndromes or complex regional pain syndromes.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Spinal cord stimulation

    Procedure/Surgery

    implantation of electrode which is linked to an implantable impulse generator for the treatment of chronic pain syndromes.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Pain intensity after 21 days

Follow-up of pain intensity (measured by the Numeric Rating Scale, with a minimum of 0 and a maximum score of 10) during the trial therapy of 21 days, together with quality of sleep and quality of ambulation (also ona NRS scale from 0 to 10).

Time frame
21 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.